InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Hansen Gwenn, Chief Scientific Officer. Officer active across 1 companies, notably Nurix Therapeutics, Inc.. In total, 25 disclosures have been logged. The latest transaction was disclosed on 30 October 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations25 total
03,207 shares0
Common Stock
SEC:0001817160-25-000005·
03,207 shares0
Common Stock
SEC:0001817160-25-000005:0·
03,206 shares0
Common Stock
SEC:0001209191-22-026892:0·
€2,553400 shares@ €6.38330.0001% mcap6.9% of flow
Common Stock
SEC:0001209191-22-000730·
€2,553400 shares@ €6.38330.0001% mcap3.5% of flow
Common Stock
SEC:0001209191-22-000730:0·
€2,563400 shares@ €6.40760.0001% mcap6.9% of flow
Common Stock
SEC:0001209191-21-067685·
€2,563400 shares@ €6.40760.0001% mcap3.5% of flow
Common Stock
SEC:0001209191-21-067685:0·
€2,513400 shares@ €6.28210.0001% mcap6.8% of flow
Common Stock
SEC:0001209191-21-062466·
€2,513400 shares@ €6.28210.0001% mcap3.4% of flow
Common Stock
SEC:0001209191-21-062466:0·
€2,503400 shares@ €6.25860.0001% mcap6.8% of flow
Common Stock
SEC:0001209191-21-061973·
€2,503400 shares@ €6.25860.0001% mcap3.4% of flow
Common Stock
SEC:0001209191-21-061973:0·
€2,509400 shares@ €6.27240.0001% mcap6.8% of flow
Common Stock
SEC:0001209191-21-059064·
€2,509400 shares@ €6.27240.0001% mcap3.4% of flow
Common Stock
SEC:0001209191-21-059064:0·
€9,8081,600 shares@ €6.12990.0005% mcap26.5% of flow
Common Stock
SEC:0001209191-21-055171·
€9,8081,600 shares@ €6.12990.0005% mcap13.3% of flow
Common Stock
SEC:0001209191-21-055171:0·
€2,453400 shares@ €6.13130.0001% mcap6.6% of flow
Common Stock
SEC:0001209191-21-054434·
€2,453400 shares@ €6.13130.0001% mcap3.3% of flow
Common Stock
SEC:0001209191-21-054434:0·
€2,446400 shares@ €6.11390.0001% mcap6.6% of flow
Common Stock
SEC:0001209191-21-049420·
€2,446400 shares@ €6.11390.0001% mcap3.3% of flow
Common Stock
SEC:0001209191-21-049420:0·
€2,451400 shares@ €6.12850.0001% mcap6.6% of flow
Common Stock
SEC:0001209191-21-044868·
€2,451400 shares@ €6.12850.0001% mcap3.3% of flow
Common Stock
SEC:0001209191-21-044868:0·
€2,377400 shares@ €5.94220.0001% mcap6.4% of flow
Common Stock
SEC:0001209191-21-037263·
€2,377400 shares@ €5.94220.0001% mcap3.2% of flow
Common Stock
SEC:0001209191-21-037263:0·
€4,815800 shares@ €6.01930.0003% mcap13.0% of flow
Common Stock
SEC:0001209191-21-029883·
€4,815800 shares@ €6.01930.0003% mcap6.5% of flow
Common Stock
SEC:0001209191-21-029883:0·
25 of 25 declarations
About Hansen Gwenn
Hansen Gwenn is the Chief Scientific Officer of Nurix Therapeutics, Inc. He oversees the company's research and development initiatives.
